In the past decades, our knowledge about the relationship between cancer and the immune
system has increased considerably. Recent years' success of cancer immunotherapy …

Human cancers represent complex structures, which display substantial inter-and intratumor
heterogeneity in their genetic expression and phenotypic features. However, cancers …

Cancer immunotherapy is changing the imaging evaluation of cancer treatment response
and treatment-related toxic effects. New emerging patterns of treatment response and …

The impressive development of cancer immunotherapy in the last few years originates from
a more precise understanding of control mechanisms in the immune system leading to the …

Tumors are often characterized by hypoxia, vascular abnormalities, low extracellular pH,
increased interstitial fluid pressure, altered choline-phospholipid metabolism, and aerobic …

Significant advances in the genetic and molecular characterization of cancer have led to the
development of effective immunotherapies. These therapeutics help the host immune …

In recent years, various systemic immunotherapies have been developed for cancer
treatment, such as monoclonal antibodies (mABs) directed against immune checkpoints …

Stem cell (SC) therapies displayed encouraging efficacy and clinical outcome in various
disorders. Despite this huge hype, clinical translation of SC therapy has been disheartening …

In cancer-drug development, a number of different end points have been used to establish
efficacy and support regulatory approval, such as overall survival, progression-free survival …

In vivo cell tracking has emerged as a much sought after tool for design and monitoring of
cell-based treatment strategies. Various techniques are available for pre-clinical animal …